TG Therapeutics
TGTX
TGTX
91 hedge funds and large institutions have $101M invested in TG Therapeutics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
52% less capital invested
Capital invested by funds: $208M → $101M (-$107M)
93% less call options, than puts
Call options by funds: $57K | Put options by funds: $779K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
91
Holding in Top 10
–
Calls
$57K
Puts
$779K
Top Buyers
| 1 | +$718K | |
| 2 | +$678K | |
| 3 | +$657K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$527K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$503K |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$15.5M | |
| 3 | -$4.97M | |
| 4 |
BM
Bridger Management
New York
|
-$1.32M |
| 5 |
FAM
Fred Alger Management
New York
|
-$542K |